Heather Preston, Director at Karuna Therapeutics, Inc. (KRTX), bought 185 shares at $70.00 ($13K) on 2019-12-31, disclosed to the SEC on 2020-01-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| AKUS | BUY | 2020-07-02 | $5.1M | — | Filing → |
| KRTX | BUY | 2020-03-12 | $227K | — | Filing → |
| KRTX | BUY | 2020-01-10 | $56K | — | Filing → |